UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results

July 24, 2020 at 8:00 AM EDT

SAN FRANCISCO, July 24, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced it will report financial results for the second quarter ended June 30, 2020, on Friday, July 31, 2020 after NASDAQ market close.

UNITY will not conduct a conference call in conjunction with the financial results press release.

UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby provide transformative benefit in age-related diseases, such as osteoarthritis, eye diseases, neurological diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter.

Endurance Advisors
Mike Zanoni

Canale Communications
Jason Spark

UNITY color transp BG.jpg

Source: Unity Biotechnology, Inc.